Related Experiment Videos
Upper respiratory tract infections in the immunocompromised host
1Minneapolis Veterans Affairs Medical Center, MN 55417, USA.
Seminars in Respiratory Infections
|March 1, 1995
Summary
Upper respiratory tract infections pose significant risks for immunocompromised patients. Early diagnosis and prompt antimicrobial treatment are crucial for survival and preventing complications.
Area of Science:
- Infectious Diseases
- Immunology
- Otolaryngology
Background:
- Upper respiratory tract infections (URTIs) are a leading cause of illness and death in immunocompromised individuals.
- The specific immune deficiency in a patient determines the risk and type of URTI.
- URTIs can affect various upper airway structures and may lead to severe complications.
Purpose of the Study:
- To highlight the risks and clinical presentations of URTIs in immunocompromised patients.
- To emphasize the importance of early diagnosis and treatment of URTIs in this population.
- To discuss the role of prophylactic antimicrobial therapy.
Main Methods:
- Literature review of URTIs in immunocompromised hosts.
- Analysis of infection types, risk factors, and clinical manifestations.
- Review of treatment and prophylaxis strategies.
Main Results:
- Immunocompromised patients are susceptible to a wide range of URTIs, often with atypical presentations.
- Infections can involve the oral cavity, pharynx, larynx, trachea, ears, and sinuses.
- Complications include abscess formation and spread to critical structures.
Conclusions:
- A high index of suspicion is necessary for diagnosing URTIs in immunocompromised patients.
- Prompt antimicrobial therapy is often life-saving.
- Prophylaxis with antibiotics, antifungals, or antivirals is indicated for specific patient groups.